- Home
- ZCAR vs EVOK Comparison
ZCAR vs EVOK Comparison
Compare ZCAR & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCAR
- EVOK
- Stock Information
- Founded
- ZCAR 2013
- EVOK 2007
- Country
- ZCAR India
- EVOK United States
- Employees
- ZCAR N/A
- EVOK N/A
- Industry
- ZCAR Blank Checks
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- ZCAR Finance
- EVOK Health Care
- Exchange
- ZCAR Nasdaq
- EVOK Nasdaq
- Market Cap
- ZCAR 8.8M
- EVOK 7.1M
- IPO Year
- ZCAR N/A
- EVOK 2013
- Fundamental
- Price
- ZCAR $1.14
- EVOK $4.67
- Analyst Decision
- ZCAR
- EVOK
- Analyst Count
- ZCAR 0
- EVOK 0
- Target Price
- ZCAR N/A
- EVOK N/A
- AVG Volume (30 Days)
- ZCAR 313.9K
- EVOK 9.6K
- Earning Date
- ZCAR 02-14-2025
- EVOK 03-13-2025
- Dividend Yield
- ZCAR N/A
- EVOK N/A
- EPS Growth
- ZCAR N/A
- EVOK N/A
- EPS
- ZCAR 1.91
- EVOK N/A
- Revenue
- ZCAR $9,089,489.00
- EVOK $8,617,036.00
- Revenue This Year
- ZCAR N/A
- EVOK $97.35
- Revenue Next Year
- ZCAR N/A
- EVOK $99.52
- P/E Ratio
- ZCAR $0.61
- EVOK N/A
- Revenue Growth
- ZCAR N/A
- EVOK 100.35
- 52 Week Low
- ZCAR $1.00
- EVOK $3.54
- 52 Week High
- ZCAR $186.00
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- ZCAR 31.70
- EVOK 50.36
- Support Level
- ZCAR $1.03
- EVOK $4.68
- Resistance Level
- ZCAR $1.95
- EVOK $5.00
- Average True Range (ATR)
- ZCAR 0.17
- EVOK 0.31
- MACD
- ZCAR 0.03
- EVOK 0.02
- Stochastic Oscillator
- ZCAR 7.77
- EVOK 42.45
About ZCAR Zoomcar Holdings Inc.
Zoomcar Holdings Inc is India's largest marketplace for cars on rent. Zoomcar is a leading emerging-market-focused peer-to-peer car-sharing marketplace, with approximately 21,000 vehicles registered through its platform. The Company derives its revenue principally from short-term self-drive rentals and vehicle subscriptions. The self-drive rental business generates the majority of revenue. Geographically The company operates in India, Egypt, Indonesia, Vietnam, and the Philippines, Out of which the majority of revenue is derived from India.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.